# Zivo Bioscience Inc. (ZIVO)

Source: https://www.quantisnow.com/company/ZIVO
Generated: 2026-11-18T23:28:38.670Z

- Ticker: ZIVO
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0001101026
- Website: zivobioscience.com

## About

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Keego Harbor, Michigan.

## Latest ZIVO news and filings

- 2026-04-24 22:16 UTC [Insider Buy] [Large owner Strome Mark E bought $200,000 worth of shares (100,000 units at $2.00) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-strome-mark-e-bought-200000-worth-of-shares-6515110)
- 2026-04-06 12:00 UTC [ZIVO Bioscience Secures Commercial-Scale Manufacturing Agreement with Cyanotech Corporation for Zivolife™ Algal Biomass](https://www.quantisnow.com/insight/zivo-bioscience-secures-commercial-scale-manufacturing-agreement-with-cyanotech-corporation-for-6488689)
- 2026-04-02 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Zivo Bioscience Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-zivo-bioscience-inc-6483111)
- 2026-03-30 12:01 UTC [SEC Form 8-K] [Zivo Bioscience Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/zivo-bioscience-inc-filed-sec-form-8-k-leadership-update-regulation-6475947)
- 2026-03-27 20:43 UTC [ZIVO Bioscience Provides Special Letter to Shareholders](https://www.quantisnow.com/insight/zivo-bioscience-provides-special-letter-to-shareholders-6474982)
- 2026-03-03 21:06 UTC [Insider Buy] [Director Yaldoo Laith L bought $14,998 worth of shares (1,543 units at $9.72) (SEC Form 4)](https://www.quantisnow.com/insight/director-yaldoo-laith-l-bought-14998-worth-of-shares-1543-6425013)
- 2026-02-28 01:20 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Zivo Bioscience Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-zivo-bioscience-inc-6420280)
- 2026-02-17 11:22 UTC [Insider Buy] [Large owner Strome Mark E bought $195,400 worth of shares (20,000 units at $9.77) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-strome-mark-e-bought-195400-worth-of-shares-6393962)
- 2026-02-12 14:21 UTC [Insider Buy] [Director Yaldoo Laith L bought $24,997 worth of shares (2,434 units at $10.27) (SEC Form 4)](https://www.quantisnow.com/insight/director-yaldoo-laith-l-bought-24997-worth-of-shares-2434-6388696)
- 2026-01-28 21:11 UTC [Insider Buy] [Director Cornell Alison A bought $99,995 worth of shares (11,709 units at $8.54), increasing direct ownership by 4% to 279,481 units (SEC Form 4)](https://www.quantisnow.com/insight/director-cornell-alison-a-bought-99995-worth-of-shares-11709-6364053)
- 2026-01-28 21:06 UTC [Insider Buy] [President and CEO Payne John Bernard bought $99,995 worth of shares (11,709 units at $8.54), increasing direct ownership by 148% to 19,618 units (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-payne-john-bernard-bought-99995-worth-of-6363988)
- 2026-01-27 22:09 UTC [Insider Buy] [Director Maggiore Christopher D. bought $14,993 worth of shares (1,766 units at $8.49), increasing direct ownership by 0.34% to 519,292 units (SEC Form 4)](https://www.quantisnow.com/insight/director-maggiore-christopher-d-bought-14993-worth-of-shares-1766-6362713)
- 2026-01-27 22:09 UTC [Insider Buy] [Director Yaldoo Laith L bought $14,993 worth of shares (1,766 units at $8.49) (SEC Form 4)](https://www.quantisnow.com/insight/director-yaldoo-laith-l-bought-14993-worth-of-shares-1766-6362710)
- 2025-12-29 22:06 UTC [SEC Form 3] [New insider Sullivan William A. claimed no ownership of stock in the company (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-sullivan-william-a-claimed-no-ownership-of-stock-6328911)
- 2025-12-23 21:06 UTC [SEC Form 8-K] [Zivo Bioscience Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/zivo-bioscience-inc-filed-sec-form-8-k-leadership-update-financial-6326711)
- 2025-12-02 23:43 UTC [Insider Buy] [Director Yaldoo Laith L bought $24,993 worth of shares (2,777 units at $9.00) (SEC Form 4)](https://www.quantisnow.com/insight/director-yaldoo-laith-l-bought-24993-worth-of-shares-2777-6300362)
- 2025-11-14 21:39 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Zivo Bioscience Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-zivo-bioscience-inc-6281102)
- 2025-10-20 20:19 UTC [Insider Buy] [Large owner Strome Mark E bought $249,996 worth of shares (20,259 units at $12.34) (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-strome-mark-e-bought-249996-worth-of-shares-6238855)
- 2025-10-14 22:10 UTC [Insider Buy] [Director Yaldoo Laith L bought $19,991 worth of shares (1,659 units at $12.05) (SEC Form 4)](https://www.quantisnow.com/insight/director-yaldoo-laith-l-bought-19991-worth-of-shares-1659-6232932)
- 2025-10-09 20:28 UTC [Insider Buy] [Director Maggiore Christopher D. bought $284,421 worth of shares (23,682 units at $12.01), increasing direct ownership by 5% to 517,526 units (SEC Form 4)](https://www.quantisnow.com/insight/director-maggiore-christopher-d-bought-284421-worth-of-shares-23682-6229079)
- 2025-10-07 00:36 UTC [SEC Form 4] [SEC Form 4 filed by Director Yaldoo Laith L](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-yaldoo-laith-l-6225225)
- 2025-10-07 00:30 UTC [SEC Form 4] [SEC Form 4 filed by Director Maggiore Christopher D.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-maggiore-christopher-d-6225223)
- 2025-10-07 00:23 UTC [SEC Form 4] [SEC Form 4 filed by Director Cornell Alison A](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-cornell-alison-a-6225220)
- 2025-10-03 01:19 UTC [Insider Buy] [Director Yaldoo Laith L bought $244,999 worth of shares (15,322 units at $15.99) (SEC Form 4)](https://www.quantisnow.com/insight/director-yaldoo-laith-l-bought-244999-worth-of-shares-15322-6221479)
- 2025-09-10 13:49 UTC [SEC Form 8-K] [Zivo Bioscience Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/zivo-bioscience-inc-filed-sec-form-8-k-regulation-fd-disclosure-6196169)
- 2025-09-10 12:30 UTC [ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses](https://www.quantisnow.com/insight/zivo-bioscience-ceo-letter-to-shareholders-highlights-progress-with-human-6196008)
- 2025-08-18 20:12 UTC [SEC Form 8-K] [Zivo Bioscience Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/zivo-bioscience-inc-filed-sec-form-8-k-leadership-update-6170023)
- 2025-08-14 20:21 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Zivo Bioscience Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-zivo-bioscience-inc-6166470)
- 2025-07-14 20:59 UTC [SEC Form 8-K] [Zivo Bioscience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/zivo-bioscience-inc-filed-sec-form-8-k-entry-into-a-6119472)
- 2025-06-20 12:00 UTC [ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in Poultry](https://www.quantisnow.com/insight/zivo-bioscience-and-leading-global-animal-health-company-to-advance-6093087)
- 2025-06-16 21:04 UTC [Insider Buy] [Director Yaldoo Laith L bought $49,983 worth of shares (3,488 units at $14.33) (SEC Form 4)](https://www.quantisnow.com/insight/director-yaldoo-laith-l-bought-49983-worth-of-shares-3488-6088464)
- 2025-06-11 20:10 UTC [SEC Form 8-K] [Zivo Bioscience Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/zivo-bioscience-inc-filed-sec-form-8-k-submission-of-matters-6082077)
- 2025-05-15 20:10 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Zivo Bioscience Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-zivo-bioscience-inc-6042335)
- 2025-05-06 21:54 UTC [University of Delaware Study Identifies Optimal Formulation of ZIVO's Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry](https://www.quantisnow.com/insight/university-of-delaware-study-identifies-optimal-formulation-of-zivos-active-6022006)
- 2025-04-25 20:36 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Zivo Bioscience Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-zivo-bioscience-inc-6003023)
- 2025-04-25 12:30 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Zivo Bioscience Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-zivo-bioscience-inc-6001917)
- 2025-04-10 01:42 UTC [SEC Form 4] [Director Maggiore Christopher D. sold $325 worth of shares (20 units at $16.25), decreasing direct ownership by 0.00% to 507,000 units (SEC Form 4)](https://www.quantisnow.com/insight/director-maggiore-christopher-d-sold-325-worth-of-shares-20-5983316)
- 2025-04-04 12:23 UTC [Insider Buy] [Director Yaldoo Laith L bought $176,682 worth of shares (10,080 units at $17.53) (SEC Form 4)](https://www.quantisnow.com/insight/director-yaldoo-laith-l-bought-176682-worth-of-shares-10080-5977327)
- 2025-03-18 20:10 UTC [SEC Form 10-K] [SEC Form 10-K filed by Zivo Bioscience Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-zivo-bioscience-inc-5949685)
- 2025-02-06 21:36 UTC [ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry](https://www.quantisnow.com/insight/zivo-bioscience-plans-new-study-with-university-of-delaware-to-5875983)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ZIVO
- Earnings history: https://www.quantisnow.com/earnings/ZIVO
- Dividend history: https://www.quantisnow.com/dividends/ZIVO
- Insider transactions: https://www.quantisnow.com/insiders/ZIVO
- Options chain: https://www.quantisnow.com/options/ZIVO
- SEC 8-K filings only: https://www.quantisnow.com/company/ZIVO/8-k
- RSS and alerts for ZIVO: https://www.quantisnow.com/docs/rss-feeds.md
